Antioxidants and mineral supplements for slowing age-related macular degeneration

Age-related macular degeneration (AMD) is the most common cause of blindness in developed countries. The prevalence of AMD is 1.4% at 70 years of...

Calculating the risk of glaucoma

More than 1000 people have completed an online assessment in Australian pharmacies to determine their potential risk of developing glaucoma, and there's a call...

A voice for Australia and New Zealand at IPSF 2025

Australia and New Zealand had a voice at the IPSF World Congress, influencing discussions on education, practice and global health.

Reducing stroke risk in dementia patients

A commonly-used treatment for Alzheimer's disease could reduce the risk of stroke among people with dementia. The Australian-Swedish study, co-authored by Monash University researchers, focussed...

How AI might help identify adverse drug events

The development of natural language processing (NLP) capabilities is opening new avenues for pharmacovigilance and pharmacists can play a key role in the process. US...

The new normal

A new PSA report describes the digital future of Australian health care, a ‘new normal’ with pharmacists front and centre, equipped with more information...